Viewing Study NCT01108705


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:07 AM
Study NCT ID: NCT01108705
Status: TERMINATED
Last Update Posted: 2015-10-12
First Post: 2010-04-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module